Act On Key Analyst Price Target Shifts: HSBC Holdings plc (HSBC), Sabra Health Care REIT Inc. (SBRA)

You should consider shares of HSBC Holdings plc (NYSE:HSBC) and Sabra Health Care REIT Inc. (NASDAQ:SBRA) if you are looking for a great stocks to invest in. Starting with the HSBC shares, which traded at $36.33 at the close of the recent session, dropping -1.30%. On Tuesday, the company’s shares shed -$0.48 from its value which represented in intraday trading. The stock is now -14.60% lower in year-to-date (YTD) trading. HSBC’s intraday high was $36.35 while its lowest price touched $36.045. The stock’s 52-week high price is $44.93, which means the current price is at -19.14%. In terms of trading activity, the daily trading volume rose to 3648017 against 200-day average trading volume of 2,235,043 shares.

What are analyst forecasts for HSBC Holdings plc (NYSE:HSBC)?

At a consensus rating of 2.00, HSBC is trending as a streaking Moderate Sell, as it has been the case a month ago when 7 analysts called it a Moderate Sell. Two months ago, 8 analysts recommended, on average, that HSBC stock is a Moderate Sell. The Financial company’s shares’ overall bearish trend saw it close higher on Tuesday compared to its opening price of $36.30 on the day.

Forecasts for HSBC Holdings plc (NYSE:HSBC) give the stock a fair value for the growth of 12.69% from its last price. The 12-month price forecast for the stock by analysts puts the stock’s mean price target at $41.61, which means the price per share could rise by nearly $5.28. The price range target is between a low of $41.61 and a high of $41.61. The stock would need to gain by about $12.69 to hit the estimated high or 0.97% from its 12-month low.

The consensus among 3 analysts is that it is a good time for one to Hold in the HSBC Holdings plc. 0 analysts rate HSBC as a Buy, with 0 of 3 analysts rate it as a Sell. 0 have valued the stock as Overweight and 2 have recommended that investors Hold.

HSBC Holdings plc (NYSE:HSBC) Upgrades and Downgrades

In terms of rating changes, Berenberg on November 05, 2019, Downgrade HSBC Holdings plc (HSBC) at Sell. Analysts at Morgan Stanley have assigned a Underweight rating for the stock in their research note on October 09, 2019. Moreover, Jefferies analysts issued a rating of Hold for the stock on July 24, 2019. On July 17, 2019, the stock earned a Underweight rating due to an analyst call from Barclays, while analysts from Morgan Stanley on June 21, 2019 suggested that the stock is Equal-Weight.

Sabra Health Care REIT Inc. (NASDAQ:SBRA) adds $0.29 on Tuesday

The SBRA stock has risen 33.25% year-to-date and is currently trading at $21.96, which is -12.00% below its 52-week high. The company shares gained 1.34% on the day and have risen nearly 39.87% off a low hit. At current levels, Sabra Health Care REIT Inc. has a valuation of about $645.20M. As of 12/03/19, this stock has risen 0.50% during the week and closed at $21.67 in the previous session. However, recent Sabra Health Care REIT Inc. stock performance shows that SBRA shares are -9.74% down over the last month, and -1.08% down for the last three months.

Earnings per share (EPS) estimates for the current quarter are $0.13, with the trailing 12-month share earnings at $0.04. The ratio is expected to be down by -76.30% for the current year 2019 and 136.10% for next year. Over the next 5-year period, earnings per share will be 6.00%. But will the SBRA stock surprise in the current quarter results, where the $0.12 actual EPS reported on 9/29/2019 surprised by -29.40% or was lower by -$0.05 from the estimated $0.17.

Sales Growth to decline -0.10% for the year

How well will Sabra Health Care REIT Inc. perform as a business over the current quarter, year and next 5-year period? Compared to the year-ago quarter, analysts forecast the company to bring in between $148.89M and $156.76M in current quarter sales. The consensus estimated for the current quarter is $152.47M from sales. Forecasts for this fiscal year are between $555M and $659.31M and the consensus estimate for sales is at $623.06M. SBRA has its next quarter sales estimates at between $150.45M and $157.02M, with the quarter-over-quarter growth estimates at 12.10% and the annual growth forecast for the year at -0.10%.

Who owns shares in Sabra Health Care REIT Inc. (SBRA)?

Let’s briefly focus on the share ownership of the Sabra Health Care REIT Inc. (NASDAQ:SBRA) stock, where we find that 99.73% of shares are held by institutions. Vanguard Group, Inc. (The) tops the list of institutional owners as it is holding 29.39 million shares or 15.17% of shares outstanding. Cohen & Steers Inc. and Blackrock Inc. held 29.01 million and 26.62 million representing 14.98% and 13.74% respectively at the close of the last trading session. As of Sep 29, 2019, State Street Corporation accounted for 8.47 million shares at over 194.52 million. This represented 4.37% of shares outstanding. Principal Financial Group, Inc. held 7.9 million shares at over 181.31 million representing 4.08% of shares outstanding.

SBRA Insider Activity

Insider activity can also give a signal in terms of price direction. Looking at Sabra Health Care REIT Inc. (SBRA), a total of 186000 shares have been sold by insiders over the last 6 months while 76792 shares were added in the same time span. On 11/04/2019, Chairman, President & Chief Executive Officer by the name Matros Richard K sold 113000.0 shares worth $2.7 million at the price of $24.05 per share. Filings also show that Lewis Raymond J sold a total of 58000.0 shares on 8/26/2019 valued at $1.2 million. Since the last insider activity, the company’s share price has climbed 2.04%.